Goodwin Procter LLP advised Goldman Sachs & Co. LLC, Morgan Stanley and Jefferies on the deal. Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a patient-centric gene therapy…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
